Rare diseases
Investigational molecules
Locations
101 Seaport Boulevard Floor 12, 02210-2149, United States
Seaport Therapeutics Inc. focuses its clinical research on major depressive disorder, including presentations with anxious distress, in adult populations. The sponsor’s trial portfolio is centered on symptom reduction, psychiatric symptom control, and the clinical profile of investigational monotherapy approaches.
Its research activity is concentrated in mood disorders and the evaluation of treatments intended for patients living with persistent depressive symptoms.
Seaport Therapeutics Inc. runs clinical trials in conditions such as Major depression, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress
BulgariaA Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
